These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 24268586)

  • 21. Impact of FtsZ Inhibition on the Localization of the Penicillin Binding Proteins in Methicillin-Resistant Staphylococcus aureus.
    Ferrer-González E; Huh H; Al-Tameemi HM; Boyd JM; Lee SH; Pilch DS
    J Bacteriol; 2021 Jul; 203(16):e0020421. PubMed ID: 34031040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Do we have adequate antimicrobials against methicillin-resistant Staphylococcus aureus?].
    Muñoz Bellido JL; García-Rodríguez JA
    Rev Esp Quimioter; 2006 Dec; 19(4):313-6. PubMed ID: 17235398
    [No Abstract]   [Full Text] [Related]  

  • 23. Characterization of compensatory mutations associated with restoration of daptomycin-susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus and the role mprF mutations.
    Kanesaka I; Fujisaki S; Aiba Y; Watanabe S; Mikawa T; Katsuse AK; Takahashi H; Cui L; Kobayashi I
    J Infect Chemother; 2019 Jan; 25(1):1-5. PubMed ID: 30322736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination Antibiotic Exposure Selectively Alters the Development of Vancomycin Intermediate Resistance in Staphylococcus aureus.
    Zheng X; Berti AD; McCrone S; Roch M; Rosato AE; Rose WE; Chen B
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.
    Takata T; Miyazaki M; Futo M; Hara S; Shiotsuka S; Kamimura H; Yoshimura H; Matsunaga A; Nishida T; Ishikura H; Ishikawa T; Tamura K; Tsuji BT
    Scand J Infect Dis; 2013 Mar; 45(3):203-12. PubMed ID: 23113753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge.
    Llarrull LI; Fisher JF; Mobashery S
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4051-63. PubMed ID: 19470504
    [No Abstract]   [Full Text] [Related]  

  • 27. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
    French GL
    J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights and clinical perspectives of daptomycin resistance in Staphylococcus aureus: A review of the available evidence.
    Stefani S; Campanile F; Santagati M; Mezzatesta ML; Cafiso V; Pacini G
    Int J Antimicrob Agents; 2015 Sep; 46(3):278-89. PubMed ID: 26143590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental study of the efficacy of linezolid alone and in combinations against experimental meningitis due to Staphylococcus aureus strains with decreased susceptibility to beta-lactams and glycopeptides.
    Cabellos C; Garrigós C; Taberner F; Force E; Pachón-Ibañez ME
    J Infect Chemother; 2014 Sep; 20(9):563-8. PubMed ID: 24973908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.
    Lin SY; Chen TC; Chen FJ; Chen YH; Lin YI; Siu LK; Lu PL
    J Microbiol Immunol Infect; 2012 Dec; 45(6):435-41. PubMed ID: 22749725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of Sodium Bicarbonate on Wall Teichoic Acid Synthesis and β-Lactam Sensitization in NaHCO
    Ersoy SC; Gonçalves B; Cavaco G; Manna AC; Sobral RG; Nast CC; Proctor RA; Chambers HF; Cheung A; Bayer AS
    Microbiol Spectr; 2022 Dec; 10(6):e0342222. PubMed ID: 36377886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiological and clinical study of methicillin-resistant Staphylococcus aureus (MRSA) carrying VraS mutation: changes in susceptibility to glycopeptides and clinical significance.
    Kato Y; Suzuki T; Ida T; Maebashi K; Sakurai M; Shiotani J; Hayashi I
    Int J Antimicrob Agents; 2008 Jan; 31(1):64-70. PubMed ID: 18029148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of cross-resistance and β-lactam seesaw effect in glycopeptide-, lipopeptide- and lipoglycopeptide-resistant MRSA correlates with membrane phosphatidylglycerol levels.
    Hines KM; Shen T; Ashford NK; Waalkes A; Penewit K; Holmes EA; McLean K; Salipante SJ; Werth BJ; Xu L
    J Antimicrob Chemother; 2020 May; 75(5):1182-1186. PubMed ID: 32016379
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
    J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Broadening the spectrum of β-lactam antibiotics through inhibition of signal peptidase type I.
    Therien AG; Huber JL; Wilson KE; Beaulieu P; Caron A; Claveau D; Deschamps K; Donald RG; Galgoci AM; Gallant M; Gu X; Kevin NJ; Lafleur J; Leavitt PS; Lebeau-Jacob C; Lee SS; Lin MM; Michels AA; Ogawa AM; Painter RE; Parish CA; Park YW; Benton-Perdomo L; Petcu M; Phillips JW; Powles MA; Skorey KI; Tam J; Tan CM; Young K; Wong S; Waddell ST; Miesel L
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4662-70. PubMed ID: 22710113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of vancomycin nonsusceptible strains in clinical isolates of Staphylococcus aureus in northern Iran.
    Asadpour L; Ghazanfari N
    Int Microbiol; 2019 Dec; 22(4):411-417. PubMed ID: 30811005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic identification of cryptic susceptibility to penicillins and β-lactamase inhibitors in methicillin-resistant Staphylococcus aureus.
    Harrison EM; Ba X; Coll F; Blane B; Restif O; Carvell H; Köser CU; Jamrozy D; Reuter S; Lovering A; Gleadall N; Bellis KL; Uhlemann AC; Lowy FD; Massey RC; Grilo IR; Sobral R; Larsen J; Rhod Larsen A; Vingsbo Lundberg C; Parkhill J; Paterson GK; Holden MTG; Peacock SJ; Holmes MA
    Nat Microbiol; 2019 Oct; 4(10):1680-1691. PubMed ID: 31235959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Novel Membrane-Associated Auxiliary Factors AuxA and AuxB Modulate β-lactam Resistance in MRSA by stabilizing Lipoteichoic Acids.
    Mikkelsen K; Sirisarn W; Alharbi O; Alharbi M; Liu H; Nøhr-Meldgaard K; Mayer K; Vestergaard M; Gallagher LA; Derrick JP; McBain AJ; Biboy J; Vollmer W; O'Gara JP; Grunert T; Ingmer H; Xia G
    Int J Antimicrob Agents; 2021 Mar; 57(3):106283. PubMed ID: 33503451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA).
    Gould IM
    Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S17-21. PubMed ID: 23664580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A MRSA mystery: how PBP4 and cyclic-di-AMP join forces against β-lactam antibiotics.
    Gardner TM; Grosser MR
    mBio; 2024 Aug; 15(8):e0121024. PubMed ID: 39028200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.